Vein graft failure: from pathophysiology to clinical outcomes
MR De Vries, KH Simons, JW Jukema… - Nature Reviews …, 2016 - nature.com
Occlusive arterial disease is a leading cause of morbidity and mortality worldwide. Aside
from balloon angioplasty, bypass graft surgery is the most commonly performed …
from balloon angioplasty, bypass graft surgery is the most commonly performed …
[HTML][HTML] Inflammation in vein graft disease
MR De Vries, PHA Quax - Frontiers in cardiovascular medicine, 2018 - frontiersin.org
Bypass surgery is one of the most frequently used strategies to revascularize tissues
downstream occlusive atherosclerotic lesions. For venous bypass surgery the great …
downstream occlusive atherosclerotic lesions. For venous bypass surgery the great …
[HTML][HTML] Management and prevention of saphenous vein graft failure: a review
P McKavanagh, B Yanagawa, G Zawadowski… - Cardiology and …, 2017 - Springer
Coronary artery bypass grafting (CABG) remains a vital treatment for patients with
multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the …
multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the …
[HTML][HTML] Coronary artery bypass: review of surgical techniques and impact on long-term revascularization outcomes
B McNichols, JR Spratt, J George, S Rizzi… - Cardiology and …, 2021 - Springer
Coronary revascularization for multivessel disease remains a common and costly source of
hospitalizations in the United States. Surgical techniques influence outcomes for coronary …
hospitalizations in the United States. Surgical techniques influence outcomes for coronary …
Revascularisation of type 2 diabetics with coronary artery disease: Insights and therapeutic targeting of O-GlcNAcylation
Aim Coronary artery bypass graft (CABG) using autologous saphenous vein continues to be
a gold standard procedure to restore the supply of oxygen-rich blood to the heart muscles in …
a gold standard procedure to restore the supply of oxygen-rich blood to the heart muscles in …
[HTML][HTML] A single-cell survey of cellular heterogeneity in human great saphenous veins
Y Sun, X Hu, K Zhang, M Rao, P Yin, R Dong - Cells, 2022 - mdpi.com
Background: The great saphenous vein (GSV) is the most commonly used conduit for
coronary arterial bypass graft. However, the status of the GSV, including metabolic …
coronary arterial bypass graft. However, the status of the GSV, including metabolic …
Incidence, predictors, and outcomes of in-hospital percutaneous coronary intervention following coronary artery bypass grafting
F Alqahtani, KM Ziada, V Badhwar, G Sandhu… - Journal of the American …, 2019 - jacc.org
Background: Post-operative acute coronary ischemia is an uncommon complication of
coronary artery bypass grafting (CABG). However, data on the incidence and outcomes of …
coronary artery bypass grafting (CABG). However, data on the incidence and outcomes of …
[HTML][HTML] Biomarkers in coronary artery bypass surgery: ready for prime time and outcome prediction?
Coronary artery bypass surgery (CABG) is still one of the most frequently performed surgical
procedures all over the world. The results of this procedure have been constantly improved …
procedures all over the world. The results of this procedure have been constantly improved …
Current role of saphenous vein graft in coronary artery bypass grafting
Saphenous vein was the conduit used in the first series of coronary artery bypass grafting
(CABG), and, with the exception of surgical revascularization of the left anterior descending …
(CABG), and, with the exception of surgical revascularization of the left anterior descending …
Is transfusion associated with graft occlusion after cardiac operations?
M Engoren, TA Schwann, E Jewell, S Neill… - The Annals of thoracic …, 2015 - Elsevier
Background Packed red blood cell (RBC) transfusions are associated with increased
mortality after coronary artery bypass grafting (CABG) but not after cardiac valve operations …
mortality after coronary artery bypass grafting (CABG) but not after cardiac valve operations …